Browse grants
Federal opportunities with plain-English eligibility summaries. We aggregate public records — always verify the details on the funder’s site before applying.
Kidney, Urologic, and Hematologic Diseases - Fostering the AdvanceMent of an Interactive Learning communitY - Coordinating Center (KUH-FAMILY) (U24- Clinical Trials Not Allowed)
Due in 10 daysNational Institutes of Health · Amount varies
The Division of Kidney, Urologic, and Hematologic Diseases (KUH) at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) currently supports several institutional and individual training and career development programs. The purpose of this Notice of Funding Opportunity (NOFO) is to establish a single Coordinating Center to unite and harmonize these programs, which collectively aim to recruit, train, and retain an active, national community of researchers in KUH mission areas across career stages. This highly integrated community will be called KUH-FAMILY (Kidney, Urologic, and Hematologic Diseases - Fostering the AdvanceMent of an Interactive Learning communitY).
BRAIN Initiative: Production and distribution facilities for brain cell type-specific access reagents (U24 Clinical Trial Not Allowed)
Due in 10 daysNational Institutes of Health · Amount varies
This BRAIN Initiative Notice of Funding Opportunity (NOFO) is to support scaled reagent production and distribution facilities involving technologies to access brain cell types. Facilities for production and distribution of these reagents by a broad set of neuroscientists will be encouraged. This NOFO is part of the BRAIN Initiative Armamentarium for Brain Cell Access transformative project. Efforts will be supported to produce and distribute gene transfer, gene regulation, and genome engineering reagents for use in both genetically tractable and less tractable systems, including primates and human tissue, which are relevant for future translational efforts. Reagents to be produced and distributed are those designed and validated under other NOFOs from the Armamentarium transformative project.
Research Grants for Preventing Interpersonal Violence and Suicide Among Youth and Young Adults (R01)
Due in 10 daysCenters for Disease Control and Prevention - ERA · $0–$400K
This initiative is intended to support effectiveness research to evaluate innovative programs, practices, or policies to address risk for interpersonal violence and suicide among groups experiencing a high burden of these issues. Innovative approaches are those that have not been rigorously evaluated for effectiveness in reducing interpersonal violence or suicide. Analyses examining how the approach affects different populations that are most impacted by these issues are a priority. Funds are available to conduct studies focused on preventing interpersonal violence or suicide involving youth or young adults (ages 10–24 years), including child abuse and neglect, intimate partner violence, sexual violence, suicide, and youth violence.
INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)
Due in 10 daysNational Institutes of Health · Amount varies
The purpose of the INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Predoctoral to postdoctoral Fellow Transition award (F99/K00) is to recruit exceptional graduate students from a variety of research fields to pursue postdoctoral training focused on Down syndrome related research. Talented graduate students from disciplines including, but not limited to, genetics, biochemistry, data science, imaging, engineering and neurobiology are invited to apply to this opportunity. Prospective applicants are strongly encouraged to contact the INCLUDE Program Staff prior to initiating plans for application submission.
Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases
Due in 10 daysCenters for Disease Control - NCEZID · $200K–$30M
This cooperative agreement establishes a single, integrated funding mechanism aimed at enhancing the nation's ability to prevent, detect, and respond to infectious disease threats. It will support clinicians, healthcare professionals, healthcare systems, institutions, and organizations directly involved in patient care, public health, and infectious disease control across the United States. By strengthening the capacity of these key stakeholders, the program will enable more effective frontline engagement, facilitate the implementation of timely public health responses, and generate expert insights to inform and improve public health guidance and practice.The program will focus on building and sustaining critical infrastructure, workforce training, communication strategies, and emergency response capabilities needed to address both emerging and reemerging infectious diseases. Emphasis will be placed on expanding national infection prevention capacity through targeted education and training initiatives, particularly in the areas of antimicrobial resistance and infection control. Additionally, the program will enhance preparedness by supporting surge staffing and fostering coordination among healthcare and public health partners during emergency response efforts.
Revolving Fund Program
Due in 12 daysRural Utilities Service · $0
This program provides grants to qualified private, non-profit entities to capitalize revolving funds for the purpose of providing financing to eligible entities for pre-development costs associated with proposed water and wastewater projects or with existing water and wastewater systems, and short-term costs incurred for replacement equipment, small-scale extension of services, or other small capital projects that are not part of the regular operations and maintenance activities of existing water and wastewater systems.
Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)
Due in 14 daysNational Institutes of Health · Amount varies
The purpose of this Funding Opportunity Announcement (FOA) is to stimulate HIV/AIDS research within the scientific mission areas of the National Institute on Deafness and Other Communications Disorders (NIDCD). Applications should address high priority HIV/AIDS research outlined by the NIH Office of AIDS Research (OAR) [https://www.oar.nih.gov/hiv-policy-and-research/research-priorities] in the areas of hearing, balance, taste, smell, voice, speech, and language.For applications proposing a clinical trial, only low risk clinical trials will be supported.
Eliminating Parasitic and Neglected Tropical Disease Threats to the United States - Program Support and Research to Reduce Threats to Americans at Home and Abroad
Due in 15 daysCenters for Disease Control and Prevention - ERA · $500K–$1M
The purpose of this notice of funding opportunity (NOFO) is to expand the network of institutes working with CDC to help eliminate or control non-malaria parasitic threats and neglected tropical diseases (NTDs). This NOFO will focus on threats and diseases that may affect Americans at home or abroad or whose elimination or control would serve other U.S. priorities. This program will also support research that will provide tools and information to improve NTD and parasitic disease program activities. The program will also integrate evaluation and surveillance activities for multiple NTDs and other parasitic diseases.
Adult Suicide Prevention
Due in 15 daysSubstance Abuse and Mental Health Services Adminis · $0–$400K
The purpose of this program is to build and strengthen community infrastructure and readiness to support early intervention, community-led suicide prevention, and resiliency efforts for adults who are at risk for suicide.
Providers Clinical Support System - Universities
Due in 15 daysSubstance Abuse and Mental Health Services Adminis · $0–$300K
The purpose of this program is to fully prepare graduate-level health professional students to understand, identify, intervene, and treat patients with a substance use, misuse and substance use disorder upon becoming licensed practitioners.
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
Due in 15 daysNational Institutes of Health · Amount varies
The purpose of this notice of funding opportunity (NOFO) is to support translational and clinical research to (1) advance precision medicine in pregnant women, lactating women, and children through the development of novel tools, models, and other technologies that could have a direct clinical or health impact; (2) enhance the understanding of the underlying mechanisms of drug action, including the role of pediatric ontogeny and the dynamic physiological changes that occur during pregnancy and lactation; and (3) discover and develop novel therapeutics or enhance the usage of existing drugs or drug repurposing for safer and more effective medications in pregnant and lactating women, neonates, and children. The overall goal is to improve safe and effective precision therapeutics for pregnant and lactating women, fetuses, neonates, and children, including those with disabilities.
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
Due in 16 daysNational Institutes of Health · Amount varies
The purpose of this notice of funding opportunity (NOFO) is to support translational and clinical research to (1) advance precision medicine in pregnant women, lactating women, and children through the development of novel tools, models, and other technologies that could have a direct clinical or health impact; (2) enhance the understanding of the underlying mechanisms of drug action, including the role of pediatric ontogeny and the dynamic physiological changes that occur during pregnancy and lactation; and (3) discover and develop novel therapeutics or enhance the usage of existing drugs or drug repurposing for safer and more effective medications in pregnant and lactating women, neonates, and children. The overall goal is to improve safe and effective precision therapeutics for pregnant and lactating women, fetuses, neonates, and children, including those with disabilities.
Single Source: Cardiothoracic Surgical Trials Network (CTSN) Data Coordinating Center (U01 Clinical Trial Required)
Due in 16 daysNational Institutes of Health · Up to $8M
This is a Notice of Funding Opportunity (NOFO) for a Single Source that will invite an application from the eligible organization to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application will be peer-reviewed, and if it is not a meritorious application, it will not be funded. This single source NOFO is intended to support a Data Coordinating Center (DCC) to conduct the activities of the Cardiothoracic Surgical Trials Network (CTSN). The DCC will consist of two collaborating components including a Data Management and Analytics Center (DMAC) and a Clinical Coordination Center (CCC). NHLBI strongly encourages multi-PD/PI applications with two PDs/PIs; one PD/PI for the DMAC and one PD/PI for the CCC. The primary responsibility of the DCC is to oversee the conduct of multiple randomized clinical trials in the CTSN.The DCC will support regulatory and administrative activities, data collection and management, and statistical analysis and reporting of trial results in a timely manner. The DCC will promote collaboration and communication among CTSN investigators and the broader research community and will coordinate outreach activities including engaging foundations, research entities, and small businesses in trials of mutual interest and public health importance. The DCC is responsible for integrating the efforts of clinical sites, core laboratories, and other collaborators, and conducting long-term follow-up centrally via telephone follow-up at the DCC. The NHLBI anticipates that the DCC will manage a Clinical and Implementation Research Skills Program centrally. The clinical and implementation research scholars program will support the expanded integration of clinical skills with dissemination and implementation science scholarship to enhance implementation research capacity. The scholars program would be designed to foster additional research questions within CTSN as well as generate a cohort of researchers who would transport their scholarship as they transition to leadership positions in academic and clinical programs.
Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed)
Due in 17 daysNational Institutes of Health · Amount varies
The Center for Inherited Disease Research (CIDR) high-throughput genotyping, sequencing and supporting statistical genetics services are designed to aid the identification of genes or genetic modifications that contribute to human health and disease or to enhance existing collections of well-phenotyped specimens in biorepositories by the addition of genotype or next-generation sequence data. The laboratory specializes in genomic services that cannot be efficiently carried out in individual investigator laboratories. CIDR provides the most up-to-date platforms, services and statistical genetic support. This is an NIH-wide initiative that is managed by NHGRI. Information about current services offered can be accessed via: http://www.cidr.jhmi.edu.
Rural Health Research Dissemination Program
Due in 17 daysHealth Resources and Services Administration · $0–$230K
This notice announces the opportunity to apply for funding under the Rural Health Research Dissemination Program. The purpose of this program is to fund an entity to disseminate and promote rural health services research to broad audiences, such as decision makers and rural stakeholders at national, state, and community levels. FORHP funds health services research through the Rural Health Research Center (RHRC) Program and other cooperative agreements. The successful applicant for this program will develop and maintain a website that catalogs this research so that it is easily and freely accessible to the public. The successful applicant will also develop and maintain strategies to disseminate this research through a variety of innovative mechanisms including (but not limited to) a listserv, social media accounts, presentations, and exhibits at national conferences, and webinars.
Nursing Workforce Development (NWD)
Due in 17 daysHealth Resources and Services Administration · $1–$555K
The purpose of the Nursing Workforce Development (NWD) program is to increase nursing education opportunities for individuals from disadvantaged backgrounds.
Ryan White HIV/AIDS Program Part C Capacity Development Program 
Due in 17 daysHealth Resources and Services Administration · $0–$150K
The purpose of the Ryan White HIV/AIDS Program (RWHAP) Part C Capacity Development program is to strengthen organizational capacity to increase capacity to develop, enhance, or expand access to high quality HIV primary health care services for low-income people with HIV. The proposed activity should be of a short-term nature and should be completed by the end of the one-year funding opportunity period of performance. Activities fall under two categories: HIV Care Innovation and Infrastructure Development.
MCH Workforce Development and Training Center
Due in 17 daysHealth Resources and Services Administration · $0–$2M
The MCH Workforce Development and Training Center provides training, technical assistance, and workforce development opportunities to strengthen the current and future maternal and child (MCH) workforce. The Center equips state Title V Maternal and Child Health Services Block Grant Program (Title V) leaders, staff, and other MCH professionals with the skills and tools to address MCH needs in their communities and advance outcomes nationwide.
Rural Communities Opioid Response Program (RCORP)-Planning
Due in 17 daysHealth Resources and Services Administration · $100K
Rural Communities Opioid Response Program (RCORP)-Planning supports organizations in rural communities to build the partnerships and foundational capacity needed to develop, implement and sustain a comprehensive system of substance use disorder (SUD) and related services. RCORP"s focus is on opioid misuse and its impact on rural America. However, HRSA recognizes that people who misuse opioids often struggle with other substances as well, including alcohol. Individuals struggling with SUD, including opioid use disorder (OUD), need a continuum of mental, behavioral, and related social supports. RCORP-Planning helps address these needs in a comprehensive way.This program is intended for rural communities that may find the logistics or requirements of larger, more complex federal grant programs to be barriers to accessing start-up support. Funding will serve as a critical first step to creating SUD service systems that make care easy to access, strengthen the behavioral health workforce, and have strong community buy-in. It will help prepare communities to provide sustainable prevention, treatment, recovery, and other supportive services that:reduce substance use initiation and misuse,address the mental, behavioral, and psychosocial needs of people who use illicit substances or misuse alcohol, or are in recovery from substance use problems, andreduce disease and death related to substance use problems, including OUD, in high-risk rural communities.The intent of this program is to fund planning activities only. Funds may not be used for direct service delivery.
Rural Community Health Support Program
Due in 17 daysHealth Resources and Services Administration · $0–$4.5M
The purpose of the Rural Community Health Support Program cooperative agreement is to develop, deliver, and coordinate nationally available technical assistance that supports community-based organizations and rural health stakeholders serving rural populations to improve and expand delivery and access to quality care for rural communities.